Literature DB >> 8780173

Automated monitoring of apoptosis in suspension cell cultures.

V D Kravtsov1, I Fabian.   

Abstract

Cell death by apoptosis is often accompanied by extensive DNA cleavage at internucleosomal linker sites. Thus, the foremost techniques for estimating apoptosis are based on biochemical, electrophoretic, or flow cytometry analysis of nuclear DNA. However, apoptosis is also associated with a chain of morphologic changes in the nuclear and cytoplasmic structures that are easily recognizable using light microscopy. We suggest that changes in morphology of cells undergoing apoptosis might cause characteristic changes in their optical properties. It follows that continuous measuring of the OD of cells undergoing apoptosis would enable the study of the kinetics of cell death. We recently described an automated microculture kinetic (MiCK) assay that provides multiple OD measurements in nondisrupted cell cultures. In the present study the MiCK assay was employed to follow OD changes in HL-60 and OCI/AML-3 myelogenous leukemia cells and murine thymocytes exposed to ethanol, hydrogen peroxide, etoposide, cisplatin, doxorubicin, or hyperthermia; i.e., divers stimuli known to induce cell death via apoptosis or necrosis. The MiCK assay revealed prominent differences between the optical properties of the cells undergoing the two different modes of death. Plotting the OD data accumulated during the assay period against time betrayed characteristic patterns of either "apoptotic" or "necrotic" OD curves. The best fit slope of the indicative of apoptosis steep rising component of the apoptotic curve, correlated directly with the percentage of morphologically apoptotic cells in the culture. Criteria for graphical estimate of apoptosis were suggested and used to study apoptosis induced in HL-60 cells by the chemotherapy compounds etoposide and cisplatin. The MiCK assay demonstrated markedly varying time courses of the cell apoptotic response to these two drugs. In both cases, however, the time of graphically predicted peaks of apoptosis correlated with the time of morphologically and electrophoretically recognized peaks of apoptosis. Adaptability of the MiCK assay to a 96-well microplate format opens the way for large-scale studying of cell apoptotic response to various stimuli. An important technical advantage of the automated MiCK assay of apoptosis is that it does not require additional laboratory procedures after microcultures are initiated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8780173

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  6 in total

1.  Comparative analysis of different methodological approaches to the in vitro study of drug-induced apoptosis.

Authors:  V D Kravtsov; T O Daniel; M J Koury
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

2.  Endometrial carcinoma in vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic apoptosis assay: implications for endometrial cancer treatment.

Authors:  Karen S Ballard; Howard D Homesley; Charles Hodson; Cary A Presant; James Rutledge; Allan Hallquist; Mathieu Perree
Journal:  J Gynecol Oncol       Date:  2010-03-31       Impact factor: 4.401

3.  Apoptosis- and necrosis-induced changes in light attenuation measured by optical coherence tomography.

Authors:  Freek J van der Meer; Dirk J Faber; Maurice C G Aalders; Andre A Poot; Istvan Vermes; Ton G van Leeuwen
Journal:  Lasers Med Sci       Date:  2010-03       Impact factor: 3.161

4.  Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response.

Authors:  Emery Salom; Manuel Penalver; Howard Homesley; Matthew Burrell; Audrey Garrett; Cary A Presant; James Rutledge; Michael Chernick; Allan Hallquist; Mathieu Perree
Journal:  J Transl Med       Date:  2012-08-08       Impact factor: 5.531

5.  Application of a drug-induced apoptosis assay to identify treatment strategies in recurrent or metastatic breast cancer.

Authors:  Linda Bosserman; Karl Rogers; Carl Willis; Dirk Davidson; Pat Whitworth; Misagh Karimi; Gargi Upadhyaya; James Rutledge; Allan Hallquist; Mathieu Perree; Cary A Presant
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

6.  Clinical utility of circulating tumor-associated cells to predict and monitor chemo-response in solid tumors.

Authors:  Timothy Crook; Andrew Gaya; Raymond Page; Sewanti Limaye; Anantbhushan Ranade; Amit Bhatt; Sanket Patil; Prashant Kumar; Darshana Patil; Dadasaheb Akolkar
Journal:  Cancer Chemother Pharmacol       Date:  2020-11-10       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.